AFP and hepatocellular carcinoma: This targeted isolation provides superior diagnostic and prognostic capabilities compared to conventional biomarkers like alpha-fetoprotein (AFP), enhancing the specificity and sensitivity of disease detection and enabling more effective personalized treatment strategies for HCC patients [155,156].